Generation Bio Co. Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Generation Bio Co. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue19.895.900.000.000.00
Cost of Revenue47.7776.9470.5674.7249.14
Gross Profit-27.88-71.04-70.56-74.72-49.14
Operating Expenses
Research & Development61.3193.6296.7285.2558.53
Selling, General & Administrative51.3167.5370.6233.8531.98
Operating Expenses51.3167.5370.62119.1031.98
Operating Income-79.19-138.56-141.18-119.10-81.11
Other Income/Expense
Interest Income10.7211.954.540.000.00
Interest Expense0.000.000.000.050.00
Other Income/Expense10.7211.954.54-0.050.59
Income
Income Before Tax-131.67-126.61-136.64-119.15-80.52
Income Tax Expense0.000.000.000.0027.86
Net Income-131.67-126.61-136.64-119.15-80.52
Net Income - Continuous Operations-131.67-126.61-136.64-119.150.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-74.26-133.30-136.05-114.57-77.68
EBIT-79.19-138.56-141.18-119.10-81.11
Depreciation & Amortization4.935.265.134.533.43
Earnings Per Share
Basic EPS-20.00-20.00-24.00-21.00-30.00
Diluted EPS-20.00-20.00-24.00-21.00-30.00
Basic Shares Outstanding6.666.455.815.632.73
Diluted Shares Outstanding6.666.455.815.632.73